Literature DB >> 29910574

Oerskovia Species Bacteremia in a Diabetic Patient.

Katerina G Oikonomou1, Carla Sue Mcwilliams1, Marwa M Moussa1.   

Abstract

Entities:  

Year:  2018        PMID: 29910574      PMCID: PMC5987366          DOI: 10.4103/jgid.jgid_67_17

Source DB:  PubMed          Journal:  J Glob Infect Dis        ISSN: 0974-777X


× No keyword cloud information.
Sir, Oerskovia species are present mainly in soil and water and are rarely pathogenic for human disease.[123] Oerskovia species represent Gram-positive rod-shaped microorganisms, which were first isolated and described as motile Nocardia.[1] The organism may be distinguished from Nocardia species by the yellow-pigmented colonies without aerial hyphae, motility, and lack of partial acid-fastness.[145] We describe the case of a patient with uncontrolled diabetes mellitus with bacteremia due to Oerskovia species. A homeless man in his early fifties presented with bilateral lower extremity pain and weakness. Physical examination was significant for multiple plantar and dorsal foot ulcerations with multiple exposed bones and tendons bilaterally. The patient was septic and was started on broad spectrum antibiotic coverage, intravenous vancomycin 1 g every 12 h, cefepime 2 g every 12 h, and metronidazole 500 mg every 8 h for severe skin and soft tissue infection and suspected chronic osteomyelitis. Blood cultures grew Oerskovia species. The most probable source of entry was the open, chronic diabetic foot wounds. In addition, we suspect that patient's severely uncontrolled diabetes mellitus resulted in impaired cellular immunity and susceptibility to invasive infection with this unusual pathogen. Due to patient's nonadherence to intravenous antibiotic administration, the regimen was switched to oral sulfamethoxazole–trimethoprim. Given the severity of infection, the patient underwent a left foot second digit and second metatarsal head resection and right foot transmetatarsal amputation. The patient completed a 21-day course of antibiotic treatment with clearance of bacteremia. Only a few cases of human infections caused by Oerskovia species have been published to date. Experience with Oerskovia species infections and outcome of treatment is limited. Further studies are required to clarify mechanisms of pathogenicity and clinical manifestations of infections due to Oerskovia species.[45]

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Oerskovia xanthineolytica: a new pathogen in bone marrow transplantation.

Authors:  P Ellerbroek; S Kuipers; M Rozenberg-Arska; L F Verdonck; E J Petersen
Journal:  Bone Marrow Transplant       Date:  1998-09       Impact factor: 5.483

2.  Oerskovia turbata and Comamonas acidovorans bacteremia in a patient with AIDS.

Authors:  M I Lair; S Bentolila; D Grenet; P Cahen; P Honderlick
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

Review 3.  CAPD peritonitis caused by co-infection with Cellulosimicrobium cellulans (Oerskovia xanthineolytica) and Enterobacter cloacae: a case report and literature review.

Authors:  Jin Sug Kim; Tae Won Lee; Chun Gyoo Ihm; Yu Jin Kim; Song Mi Moon; Hee Joo Lee; Kyung Hwan Jeong
Journal:  Intern Med       Date:  2015-01-15       Impact factor: 1.271

4.  Peritonitis caused by Oerskovia xanthineolytica in a patient on chronic ambulatory peritoneal dialysis (CAPD)

Authors:  S Borra; M Kleinfeld
Journal:  Am J Kidney Dis       Date:  1996-03       Impact factor: 8.860

5.  Oerskovia xanthineolytica bacteremia in an immunocompromised patient with pneumonia.

Authors:  C L McDonald; K Chapin-Robertson; S R Dill; R L Martino
Journal:  Diagn Microbiol Infect Dis       Date:  1994-04       Impact factor: 2.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.